Sustainable use of genetic resources under the Convention on Biological Diversity: exploring access and benefit sharing issues
The Convention on Biological Diversity is a complex document, particularly in those articles dealing with the ownership and use of genetic resources. While only limited progress has been made in applying the Convention, countries are nevertheless acting unilaterally on its placement of genetic resources as their sovereign right to exploit. There is a need to review and synthesize all of the aspects of these issues, and this book aims to fill that gap in the literature. Its focus is the presentation of legal and economic issues regarding the sustainable use and transfer of genetic resources and associated technologies. It also identifies specific steps that can be taken and their expected consequences. Drawing particularly on Articles 8, 9, 15, 16, 18 and 19 of the Convention, it will assist positive and timely action during this critical juncture in its application. It will be invaluable for scientists, policy-makers and NGOs, whether from the perspectives of economics or law, or more applied fields such as biological conservation or plant breeding and biotechnology.
42 pages matching Hence in this book
Results 1-3 of 42
What people are saying - Write a review
We haven't found any reviews in the usual places.
National Technology Transfer Commitments
Summary and Conclusions
1 other sections not shown
access legislation access to genetic agricultural and/or Andean Pact application approach Article 15 Basel Convention benefit sharing biodiversity biological diversity biotechnology Breeders capacity building Chapter collection commercial communities compensation Competent Authority complex components concept conservation Contracting Party costs developing countries economic equity established estimated example existing Farmers firms fund genebanks genetic materials germplasm Hence IARC identified implementation incentive indigenous knowledge intellectual property rights International investment involved IPR systems issues landraces limited major material transfer agreements matter mechanism ment MTAs multiple mutually agreed terms negotiating nology objectives ownership patent payments perspective pharmaceutical Philippines PIC requirements Plant Breeders plant genetic resources practical prior informed consent private sector proposed refer regulations relevant research agreements research exemption responsibility risk role royalty scope sellers sovereign rights specific suppliers technology transfer tion trade secrets traditional UPOV users variety WIPO